Close
Back to mobile site

Foundation Medicine (FMI) Misses Q4 EPS by 9c, Beats on Revenues; Offers FY18 Revenue Outlook Above Consensus

March 7, 2018 4:03 PM EST

Note: EPS may not be comparable

Foundation Medicine (NASDAQ: FMI) reported Q4 EPS of ($1.05), $0.09 worse than the analyst estimate of ($0.96). Revenue for the quarter came in at $48.9 million versus the consensus estimate of $46.21 million.

GUIDANCE:

Foundation Medicine sees FY2018 revenue of $200-220 million, versus the consensus of $194.82 million.

For earnings history and earnings-related data on Foundation Medicine (FMI) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance, Hot Guidance

Related Entities

Earnings